Juno Therapeutics
Juno Therapeutics is a Seattle-based biotechnology company developing cellular immunotherapies for cancer based on chimeric antigen receptor (CAR) T cell and T cell receptor (TCR) technologies; it listed on Nasdaq in 2014 and was acquired by Celgene in 2018.
Contents8 sections
Key facts
August 5, 2013Incorporation in Delaware
According to its prospectus, Juno Therapeutics was incorporated in Delaware on August 5, 2013, and its scientific founders and their institutions include the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center and Seattle Children’s Research Institute.[1]
December 18, 2014Initial Public Offering
The prospectus dated that day shows the company offering 11,022,917 shares of common stock at $24.00 per share, with the stock approved for listing on the Nasdaq Global Select Market under the symbol “JUNO.”[1]
2015–2016Collaboration with Celgene
According to the later acquisition announcement, Juno and Celgene entered a strategic collaboration in June 2015; in April 2016, Celgene exercised its option to develop and commercialize Juno’s CD19 program outside North America and China.[2]
January 22, 2018Celgene Announces Acquisition of Juno
Celgene announced it would acquire Juno for $87 per share in cash, an equity value of about $9 billion net of cash and marketable securities acquired and of the Juno shares Celgene already owned; the announcement said Celgene then held about 9.7% of Juno’s outstanding shares and expected the deal to close in the first quarter of 2018.[2]
March 6, 2018Acquisition Completed
Under a merger agreement dated January 21, 2018, Celgene’s wholly owned subsidiary Blue Magpie Corporation merged into Juno on March 6, 2018, with Juno surviving as a wholly owned subsidiary of Celgene.[3]
Research Focus
The acquisition announcement describes Juno as a pioneer in developing CAR T and TCR therapeutics, with its research facility in Seattle and its manufacturing facility in Bothell, Washington.[2]
Related Organizations, Websites, and Public Accounts
Juno Therapeutics: Official website: https://www.junotherapeutics.com/ (opens in a new window)[1]